Terns Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TERN research report →
About the company
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity.
- CEO
- Amy L. Burroughs
- IPO
- 2021
- Employees
- 59
- HQ
- Foster City, CA, US
Price Chart
- Market Cap
- $4.77B
- P/E
- -51.41
- P/S
- 0.00
- P/B
- 4.90
- EV/EBITDA
- -40.01
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -20.02%
- ROIC
- -10.91%
- Revenue
- $0 · 0.00%
- Net Income
- $-96,207,000 · -8.28%
- EPS
- $-1.03 · 8.04%
- Op Income
- $-110,124,000
- FCF YoY
- -17.30%
- 52W High
- $53.19
- 52W Low
- $2.65
- 50D MA
- $50.15
- 200D MA
- $29.48
- Beta
- -0.38
- Avg Volume
- 5.92M
Get TickerSpark's AI analysis on TERN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 5, 26 | Azelby Robert | sell | 90,000 |
| May 5, 26 | Azelby Robert | sell | 1,697 |
| May 5, 26 | Turner Heather D | sell | 45,000 |
| May 5, 26 | Turner Heather D | sell | 64,000 |
| May 5, 26 | Turner Heather D | sell | 1,697 |
| May 5, 26 | Tripuraneni Radhika | sell | 64,000 |
| May 5, 26 | Tripuraneni Radhika | sell | 45,000 |
| May 5, 26 | Tripuraneni Radhika | sell | 10,657 |
| May 5, 26 | Tripuraneni Radhika | sell | 4,676 |
| May 5, 26 | Tripuraneni Radhika | sell | 32,000 |
Our TERN coverage
Recent articles, reports, and earnings notes.
No research on TERN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TERN report →Similar companies
Peers in the same neighborhood.